1. Home
  2. ILAG vs OGEN Comparison

ILAG vs OGEN Comparison

Compare ILAG & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intelligent Living Application Group Inc.

ILAG

Intelligent Living Application Group Inc.

SELL

Current Price

$3.80

Market Cap

9.9M

ML Signal

SELL

Logo Oragenics Inc.

OGEN

Oragenics Inc.

HOLD

Current Price

$0.83

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ILAG
OGEN
Founded
1981
1996
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9M
3.6M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
ILAG
OGEN
Price
$3.80
$0.83
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
26.0K
98.5K
Earning Date
12-22-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,338,785.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.74
$0.74
52 Week High
$9.80
$18.90

Technical Indicators

Market Signals
Indicator
ILAG
OGEN
Relative Strength Index (RSI) 81.60 41.04
Support Level $0.30 $0.74
Resistance Level $5.26 $0.88
Average True Range (ATR) 0.22 0.05
MACD 0.42 0.00
Stochastic Oscillator 70.72 32.08

Price Performance

Historical Comparison
ILAG
OGEN

About ILAG Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.

Share on Social Networks: